Section 1115 Waiver Watch: Early Signs Point to New Directions Under Trump Administration

Recent actions from the Trump administration could signal limits to curtail Medicaid waivers related to social determinants of health and to limit waiver financing tools and flexibility. Two major changes demonstrate this shift: (1) rescinding Biden-era guidance on covering health-related social needs (HRSN) services, and (2) phasing out federal funding for “Designated State Health Programs”…

Read More

Monkeypox : Symptoms, Causes, Diagnosis & Treatment

WHO has declared monkeypox or Mpox a global emergency and pandemic, given the recent outbreak in multiple countries across the world. The Mpox virus is native to Africa, but 2022-2023 has seen Mpox outbreaks in more than 110 countries. A highly infectious disease, Mpox has already infected over 1 lakh people and has already claimed…

Read More

Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder IPF

Boehringer Ingelheim’s Jascayd blocks a protein involved in the lung inflammation that develops from idiopathic pulmonary fibrosis, a rare and ultimately fatal disease with few available therapies. The twice-daily pill doesn’t cure IPF but clinical trial results showed it slowed disease progression. The post Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder…

Read More